Aflibercept‑Yszy Suppliers & Bulk Manufacturers

Available Forms: Injectable solution

Available Strengths: 2 mg/0.05 mL

Reference Brands: Eylea(US & EU); Opuviz biosimilar to biosimilar to Eylea

Category: Biosimilars

Aflibercept‑yszy is available in Injectable solution and strengths such as 2 mg/0.05 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Aflibercept‑yszy is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Aflibercept‑yszy can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Opuviz, a biosimilar of Eylea, is regulated in the EU and US, supported by dossiers demonstrating biosimilarity, safety, efficacy, and manufacturing quality per GMP standards. In the US, FDA approval involves comprehensive clinical validation, safety assessments, and comparability data. In the EU, CE marking certifies conformity with MDR standards for biosimilars. These products undergo validation, stability testing, and audits, with detailed documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective ophthalmic biosimilars supporting effective eye disease management worldwide.